Subject of the day
HIMS
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
FY 2019–2025 · 7 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.35B | +71.4% | |
| Gross profit | $1.73B | +70.6% | |
| Operating income | $105.61M | — | |
| Net income | $128.37M | +11088.8% | |
| Cash from ops | $73.48M | +0.0% |
$28.77
▼ -1.20 (-4.0%)
| 52w hi | $62.76 |
|---|---|
| 52w lo | $14.52 |
| Vol | 12.57M |
| As of | Aug 13 |
Our score -0.07
| Short | -0.09 |
|---|---|
| Medium | +0.03 |
| Long | -0.24 |
computed 2026-08-13
Hims & Hers Health, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
| Market cap | $6.71B |
|---|---|
| Enterprise value | $7.70B |
| Trailing P/E | — |
| Forward P/E | 22.81x |
| EV / EBITDA | -756.37x |
| P / S (ttm) | 2.60x |
| Profit margin | -5.5% |
| Return on equity | -32.0% |
| Revenue growth | +38.2% |
| Earnings growth | — |
| Debt / equity | 477.13 |
| Beta vs SPX | 2.51 |
|---|---|
| Corr SPX | 0.39 |
| Annual vol | 103.2% |
| Annual ret | +83.0% |
| Sharpe | 0.80 |
| Max DD | -78.9% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.01 | |
| Sector | +0.12 | |
| Technical | -0.03 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $29.74 | $30.10 | $28.54 | $28.77 | 12.57M |
| Aug 12 | $30.48 | $30.99 | $29.25 | $29.97 | 16.91M |
| Aug 11 | $29.71 | $31.79 | $29.41 | $30.51 | 23.17M |
| Aug 10 | $31.07 | $32.29 | $30.90 | $31.77 | 17.69M |
| Aug 7 | $30.19 | $31.72 | $29.80 | $31.59 | 8.39M |